Acrivon Therapeutics Inc. (ACRV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Acrivon Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.79
+2.87% today
Market cap
$75M
Overall quality
43/100
Kronos AI 30-day
+1.2%
4 of 8 simulated paths end higher
Acrivon Therapeutics Inc. (ACRV) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $75M. It trades at $1.79, up 2.87% today. Its overall quality score is 43 out of 100, ranked against the whole US market. 4 analysts' average target of $10.50 implies +486.6% from today's price. Kronos AI's 30-day forecast is +1.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.50 |
| Low – high | $7.00 – $19.00 |
| Analysts | 4 |
| Upside to average | +486.6% |
Kronos AI 30-day forecast
| Expected close | $1.76 (+1.2%) |
| Likely range | −7.3% … +7.8% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 39 |
| Solvency | 60 |
| Growth | 31 |
| Overall | 43 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.